Subscribe

Stallion India Fluorochemicals Ltd. (STALLION.NS)

INR210.56 +7.43 (+3.66%)
IN NSE Basic Materials Chemicals - Specialty
Address 2, A Wing, Knox Plaza 400064
Mumbai, IN
CEO Shazad Sheriar Rustomji
IPO 2025-01-23
ISIN INE0RYC01010

Explore sections of this company profile

Description

Stallion India Fluorochemicals Limited focuses on the aggregation, blending, and refinement of various refrigerants and industrial gases across India. The company supplies a diverse range of fluorochemicals, encompassing hydrocarbons (HC), hydrofluorocarbons (HFC), and hydrofluoroolefins (HFO). Furthermore, they provide essential equipment and replacement parts for the air conditioning and refrigeration (AC&R) industry, such as pressure washers and vacuum pumps. Their product portfolio also includes consumer-sized aerosol cans of refrigerants like R290, R-134a, R-600a, and other hydrocarbons, in addition to paints. A comprehensive selection of refrigerants and fluorine compounds is available, featuring HFOs, various blends, HFCs and their combinations, hydrocarbons, blowing agents, propellants, electrical insulating substances, and fire extinguishants. They also offer specialized gases for semiconductor and electronics applications, including CF4 and SF6. Stallion India Fluorochemicals caters to a wide array of sectors, including air conditioning and refrigeration, fire suppression, semiconductor manufacturing, automotive production, pharmaceuticals and medical, glass bottling, aerosol packaging, defense, gas-insulated substations, and spray foam industries. Established in 1992, the company maintains its headquarters in Mumbai, India.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
INR210.56 +7.43 (+3.66%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.94
Float Shares
26.24M
Free Float %
32.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-4.00% +2.97% +15.47% +35.55% +2.66% -26.36% +119.62% +37.70% +37.70% +37.70% +37.70%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
210.56
DCF (Unlevered) 26.19 -87.6%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Quality scores
MOAT Score
3 / 10
No MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Chemicals - Specialty: +4.7%
    +14.1% Q1'26: -27.4% (vs Q1'25)
  • EPS growth Chemicals - Specialty: +13.2%
    +30.9% Q1'26: -20.4% (vs Q1'25)
  • FCF margin FCF growth · Chemicals - Specialty: +44.1%
    +10.5% Q1'26: +12.6% (vs Q1'25)
  • EBIT margin Chemicals - Specialty: +8.8%
    +13.1% Q1'26: +14.3% (vs Q1'25)
  • ROIC Chemicals - Specialty: +5.6%
    +14.9% Q1'26: +14.7% (vs Q1'25)
  • Share dilution Chemicals - Specialty: +0.1%
    +3.5% Q1'26: +3.6% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    0.60× Q1'26: 0.53× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (2.00) × ERP
WACC = 98% × Ke + 2% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 26.19 Current price: 210.56
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 B+ 3/5 1/5 4/5 5/5 3/5 2/5 4/5
2026-05-27 B+ 3/5 1/5 4/5 5/5 3/5 2/5 4/5
2026-05-26 B+ 3/5 1/5 4/5 5/5 3/5 2/5 4/5
2026-05-25 B+ 3/5 1/5 4/5 5/5 3/5 2/5 4/5
2026-05-22 B+ 3/5 1/5 4/5 5/5 3/5 2/5 4/5
2026-05-21 B+ 3/5 1/5 4/5 5/5 3/5 2/5 4/5
2026-05-20 B+ 3/5 1/5 4/5 5/5 3/5 2/5 4/5
2026-05-19 B+ 3/5 1/5 4/5 5/5 3/5 2/5 4/5
2026-05-18 B+ 3/5 1/5 4/5 5/5 3/5 2/5 4/5
2026-05-15 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-14 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-13 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-12 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-11 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-08 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-06 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-05 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-04 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-30 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-29 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-28 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-27 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-24 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-23 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-21 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-16 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
Ownership data is not available for this company yet.

Executive team

Top executives
EBIT / Employee
28.21M
Shares Outstanding
82.10M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Geetu Yadav Executive Director female
Govind Rao Company Secretary & Compliance Officer male
Manisha Shazad Rustomji Executive Director female
Rohan Shazad Rustomji Executive Director male
Shazad Sheriar Rustomji Chairman, MD & Chief Executive Officer male
Virenderkumar Mehta Chief Financial Officer male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings reports

Stock splits